“Interacting with patients, hearing what their questions are and trying to answer those questions are what drives me to do clinical research.” -Dr. Marc CarrierDr. Marc Carrier has received a major honour recognizing his outstanding contributions to advancing blood and blood vessel care in both in Canada and around the world. He is the winner of the 2022 Mid-Career Excellence Award in Blood and Blood Vessel Research, awarded jointly by the Canadian Society of Atherosclerosis, Thrombosis and Vascular Biology (CSATVB) and the Canadian Institutes of Health Research Institute of Circulatory and Respiratory Health (CIHR-ICRH).

Dr. Carrier’s research focuses on preventing and treating dangerous blood clots in the legs and lungs known as venous thromboembolism, particularly in cancer patients. Dr. Carrier’s contributions include comparing preventative blood thinners, finding a way to safety reduce blood clot risk in cancer patients and showing that it is cost-effective, and discovering that tiny clots in the lung put patients at risk of future blood clots. He also found that CT scans of the abdomen and pelvis do not improve cancer detection in people with unexplained blood clots in their legs and lungs. His research is enhancing patient care and saving lives around the world.

“Interacting with patients, hearing what their questions are and trying to answer those questions are what drives me to do clinical research,” says Dr. Marc Carrier, senior scientist and Chief of the Division of Hematology at The Ottawa Hospital, professor at the University of Ottawa

The Ottawa Hospital is a leading academic health, research and learning hospital proudly affiliated with the University of Ottawa.